Objectives: Poor adherence to immunosuppressive treatment is common in patients with systemic lupus erythematosus and may identify those with lupus nephritis (LN) who have a poorer prognosis. Non-adherence has also been reported to be a potential adverse outcome predictor in renal transplantation (rTp). We investigated whether non-adherence is associated with increased rTp graft rejection and/or failure in patients with LN. Methods: Patients with LN undergoing rTp in two major London hospitals were retrospectively included. Medical and electronic records were reviewed for documented concerns of non-adherence as well as laboratory biochemical drug levels. The role of non-adherence and other potential predictors of graft rejection/failure including demographics, comorbidities, age at systemic lupus erythematosus and LN diagnosis, type of LN, time on dialysis prior to rTp and medication use were investigated using logistic regression. Results: Out of 361 patients with LN, 40 had rTp. During a median follow-up of 8.7 years, 17/40 (42.5%) of these patients had evidence of non-adherence. A total of 12 (30.0%) patients experienced graft rejection or failure or both. In the adherent group 2/23 (8.7%) had graft rejection, whilst in the non-adherent this rose to 5/17 (29.4%, p ¼ 0.11). Graft failure was seen in 5/23 (21.7%) patients from the adherent group and 4/17 (23.5%) in the non-adherent group (p ¼ 0.89). Non-adherent patients had a trend towards increased graft rejection, hazard ratio 4.38, 95% confidence interval ¼ 0.73-26.12, p ¼ 0.11. Patients who spent more time on dialysis prior to rTp were more likely to be adherent to medication, p ¼ 0.01. Conclusion: Poor adherence to immunosuppressive therapy is common and has been shown to associate with a trend towards increased graft failure in patients with LN requiring rTp. This is the first paper to report that shorter periods on dialysis prior to transplantation might lead to increased non-adherence in lupus patients. Lupus (2019) 28, 651-657.
Introduction
According to the World Health Organization medication adherence is ''the extent to which a person's behaviour (taking medications, following a recommended diet and/or executing lifestyle changes) corresponds with the agreed recommendations of a health care provider''. 1 We and others have shown that adherence to medication is variable in patients with systemic lupus erythematosus (SLE), with poor adherence often affecting more than 50% of the patients; this might potentially be associated with worse overall prognosis. [2] [3] [4] Renal transplantation (rTp) for patients with lupus nephritis (LN) is an increasingly utilized therapy for end stage renal disease. 5, 6 However, the sparsity of suitable donors and frequent allosensitization of lupus patients due to receipt of blood products and prior pregnancies mean that most patients spend significant time on dialysis before transplantation. Poor adherence to immunosuppressive therapy has been shown to be associated with increased graft failure in renal transplant patients. Up to 16% of graft losses are attributed, in part, to poor adherence. 7, 8 It is recognized that in patients with rTp nonadherence can lead to acute and chronic rejection, reduced renal function potentially necessitating return to dialysis and even death. 9 Returning to dialysis after a failed renal transplant is associated with a 78% mortality risk compared to patients on the transplant waiting list receiving dialysis. 10 However, despite the available evidence linking non-adherence to adverse outcomes in patients with transplantation, little is known regarding adherence in patients with LN following rTp and whether less adherent patients have worse outcomes.
In this study we investigated potential factors leading to non-adherence in patients with SLE who underwent rTp for LN and whether evidence of non-adherence associates with increased renal graft rejection, defined as an acute deterioration in the graft function associated with specific histopathological changes in the graft; or with failure, defined as the need for dialysis or re-transplantation.
Methods
All patients with diagnoses of both SLE and renal failure leading to rTp from two major London hospitals (University College London Hospital and Royal Free Hospital) since 1975 were retrospectively identified and included in this study analyzing prospectively captured data. All patients fulfilled ! 4 of the 1982 revised classification criteria for SLE of the American College of Rheumatology 11 and we used the International Society of Nephrology/Renal Pathology Society 2003 classification system to define the histological class of LN. 12 Patients receiving a transplant prior to 1982 were retrospectively shown to fulfil the 1982 criteria.
We retrospectively reviewed hospital electronic and paper records and correspondence with family practitioners and with other hospital physicians to identify any documented concerns about non-adherence to prescribed immunosuppressive treatment. Such concerns would usually be documented if the patients volunteered that they were not adherent to the medication themselves, or the information came from family members or the patients admitted to this following direct questioning. Furthermore, in the United Kingdom repeat prescriptions are facilitated by the general practitioner looking after the patients in the community. Therefore, if the patients do not renew their prescriptions in the community, the general practitioner or the pharmacist will quickly become aware of this and will bring this to the attention of the clinical team for further evaluation. A recent article revealed that although patient reporting could detect even relatively infrequently missed tablets, drug monitoring could also identify severe non-adherence. 3 Thus, we also reviewed the trough blood levels recorded for patients on tacrolimus or ciclosporin and mycophenolate mofetil to help ascertain evidence of non-adherence. As there is no standard biochemical definition of non-adherence for patients with a renal transplant, we took a realistic and pragmatic approach of defining nonadherence as evidence of sub-therapeutic drug levels in routine measuring in >50% of the readings taken, at least 6 months after the rTp to avoid levels taken during the initial introduction of the medication and individual dose adjusting. We used the percentage of sub-therapeutic trough levels of immunosuppressant medication as a surrogate marker of poor adherence rather than trough level variability, as the former has been reported to be more strongly associated with graft rejection after kidney transplantation. 7 Finally, we examined potential associations with poor adherence including sex, ethnicity, age at SLE diagnosis, age at LN diagnosis, age when dialysis was started, duration of SLE diagnosis to LN, histological type of LN, time on dialysis prior to transplantation, and other existing conditions such as diabetes mellitus, hypertension, dyslipidaemia and prior cardiovascular disease. The primary endpoint was renal graft rejection (defined as acute deterioration in graft function with rejection confirmed histopathologically) occurring > 12 months from the transplantation. Secondary endpoints included renal graft failure (defined as a need for dialysis or retransplantation) and a composite endpoint of graft rejection and/or failure > 12 months from the transplant. As such, if graft failure was identified the patients were censored for the purposes of the secondary outcomes, but continued to be monitored for the primary endpoint of renal graft rejection in the second transplant. The study was a retrospective review of a long-term observational registry and, in effect, an audit for which University College London does not require formal ethical permission.
Statistical analysis
Categorical variables are presented as number and percentage whilst continuous variables are
presented as mean and standard deviation (if normally distributed) or otherwise median and interquartile range. Comparisons between groups were performed using Student's t-test for normally distributed data or the Mann-Whitney U test for other data or Fisher's exact test. Logistic regression was used to investigate the potential association between non-adherence and renal graft rejection or failure. A p < 0.05 was considered significant. IBM SPSS version 25 (IBM Corp., Armonk, NY, USA) was used for statistical analyses.
Results
Three hundred and sixty-one patients with SLE were identified with LN, the vast majority biopsy confirmed (>90%), of whom 40 had rTp for LN. A total of 17/40 (42.5%) patients were identified to be non-adherent to prescribed treatment for LN ( Figure 1 ).
As shown in Table 1 , the only significant difference between the adherent and non-adherent groups was the amount of time spent on dialysis with the adherent group spending 33 (27-79) months on dialysis versus the non-adherent group spending 17 (10-24) months on dialysis, p ¼ 0.01. There were no other significant differences in adherent and non-adherent patients. In particular, in this cohort there was no difference between the groups with regards to the age at SLE diagnosis or rTp, gender, ethnicity, diagnosis duration, medication prescribed or donor source. In addition, there were no significant differences in other comorbidities between the two groups as shown in Table 1 (all values p > 0.05). Furthermore, there was no difference in adherence versus nonadherence patterns in patients who had received Figure 1 Flow diagram indicating the study population included in this cohort. SLE: systemic lupus erythematosus. rTp prior to the year 2000 or after this time.
Moreover, there was no difference in the group that had ever received azathioprine or ciclosporin, compared to the group that had never received either of these medications in terms of adherence (all values p > 0.05). This would support the assumption that even if immunotherapeutic regimes were modified during the period of the study, this was unlikely to affect the pattern of adherence/non-adherence. One patient received three rTps in total and had a rejection on the initial transplant. Two more patients received two rTps each. One had rejection on the initial graft whilst the second one did not have evidence of rejection either on the first or second graft.
Recording a concern about non-adherence, either following medical consultation or biochemically, supported a trend to increased graft rejection. During a median follow-up of 8.7 years, 17/40 (42.5%) of patients had evidence of nonadherence (Table 1) . A total of 12 (30.0%) patients experienced graft rejection or failure or both. From the adherent group 2/23 (8.7%) had graft rejection whilst from the non-adherent group this was 5/17 (29.4%, p ¼ 0.11). Graft failure was seen in 5/23 (21.7%) patients from the adherent group and 4/17 (23.5%) in the non-adherent group (p ¼ 0.89). Using logistic regression, nonadherent patients had a trend towards increased renal graft rejection (hazard ratio 4.38, 95% confidence interval 0.73-26.12, p ¼ 0.11). There were no significant predictors for graft rejection or failure or the composite endpoint of either of them as shown in Table 2 . However, presence of class IV LN on pre-transplant histology had a trend towards a greater risk of graft rejection/failure (p ¼ 0.06).
Interestingly, a longer time on dialysis prior to the transplantation was associated with decreased non-adherence. For every additional month on dialysis non-adherence was reduced by hazard ratio 0.96, 95% confidence interval 0.93-0.99, p ¼ 0.02. A receiver operating characteristic curve (Figure 2 ) identified that spending more than 25 months on dialysis was more likely to lead to better adherence with sensitivity 0.77, specificity 0.82 and good discrimination with area under the curve¼0.76, supporting the idea that patients who spend more time on dialysis are more likely to be more adherent, and thus those with less time spent on dialysis prior to transplantation are more likely to become non-adherent. 
Discussion
In this study we considered the role of adherence to immunosuppressive treatment in patients with LN requiring rTp. We documented, for the first time, adherence patterns specifically for this cohort of patients and also investigated whether non-adherence was associated with an increased risk of graft rejection and/or failure. Our results confirmed that more than 2/5 of our patients with LN, even after rTp, were considered to be nonadherent, either based on medical record evidence or based biochemically on drug level testing.
What is particularly noteworthy is that once a concern about non-adherence was documented either in the medical notes or as evidenced with biochemical assays, there was a trend to more than a four-fold higher risk of graft rejection, indicating that poor adherence could have potentially significant adverse effects.
As this was an observational retrospective study, it was not possible to investigate causality leading to non-adherence. However, our results raise the strong possibility that patients who spend more time on dialysis are, in fact, more adherent to medication following transplantation. This is an important novel finding, as it may suggest that the time spent on dialysis has an indirect effect in encouraging better adherence post-transplant, perhaps because patients are more motivated to avoid returning to dialysis. With an increasing number of pre-emptive transplantation 6, 13 it is possible that non-adherence could also increase, and therefore the clinicians and other health care professionals should be aware and ever vigilant in recognizing this. We have recently shown that increasing time on dialysis prior to rTp adversely affects prognosis specifically in lupus patients, 14 supporting previous literature in patients with renal disease of mixed aetiology receiving rTp, 15 and therefore minimizing the time on dialysis should remain the aim. However, particular attention should be paid to the patients who spent little or no time on dialysis to ensure that non-adherence does not compromise the beneficial effects of early transplantation.
Limitations
Although we included patients from two large hospitals in London over a four-decade period, we were only able to identify 40 eligible transplanted patients from an original cohort of 361 patients. This number, although modest, is in line with or larger than other similar published studies of LN. 16, 17 Our study was retrospective; however, we endeavoured to avoid any bias by only considering strong pre-defined surrogates for non-adherence, such as clear documentation in the notes about poor adherence, or biochemical markers of nonadherence, and a well-defined endpoint of graft rejection and failure.
Moreover, we had a mixture of Caucasian, Afro-Caribbean and Asian patients and therefore our study results cannot be extrapolated to other populations. In view of this and also the relatively modest numbers in this study, we might have been underpowered to detect small but significant differences specific to individual ethnicity. As we focused our research only in the LN renal transplant patients, we are not able to comment about whether adherence in this cohort is higher or lower than the patients remaining on dialysis. In addition, the retrospective nature of the study did not allow us to screen accurately for depression, a factor known to be associated with non-adherence in the general lupus population. 18 Finally, despite one of the longest recorded follow-up periods exceeding 422 patient-years, we only had 12 patients with graft rejection or failure, which may have impacted on identifying smaller potential associations with the other variables included in this study. 
Conclusion
In conclusion, this study with a notably long-term follow-up has shown that poor adherence persists in patients with LN even after rTp. It further shows that poor adherence may be associated with worse renal graft rejection and that shorter periods on dialysis prior to transplantation might lead to increased non-adherence. This is the first study to support such a conclusion. Further research needs to be undertaken collaboratively in multiple centres to identify the true adverse role of non-adherence in patients with renal transplant due to LN. Such studies can also investigate further the factors leading to poor adherence in this cohort of patients.
Identifying patients at risk of non-adherence utilizing a combination of methods based on such factors is a key step. More importantly, patients at risk of or with documented concerns about adherence should be closely followed up with regular biochemical testing, and a purposeful discussion about the likely consequences of non-adherence in the outpatient clinics may be necessary. Finally, enhanced education sessions highlighting the importance of immunosuppressive therapy adherence could be considered for all the lupus patients following rTp but also importantly in anticipation of rTp.
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